Susannah Koontz is the Principal at Koontz Oncology Consulting LLC, where she serves as a consultant for pharmacy practice, medical education and clinical research in the fields of pediatric hematology, oncology and hematopoietic cell transplantation. She works with healthcare providers and pharmaceutical industry professionals to identify research priorities and rationally apply cancer therapies in children. Dr. Koontz has been an invited speaker at numerous international, national, and local healthcare professional meetings. Her research has been presented at several healthcare organizational conferences and published in peer-reviewed medical journals. She currently is Co-Facilitator of the HOPA Pediatric SIG and will return to the HOPA Board of Directors as President-Elect in March 2016. She has held faculty appointments at the University of Houston College of Pharmacy and the University of Texas (Austin) College of Pharmacy and has trained over two dozen PGY2 Oncology Pharmacy residents. Prior to starting her firm in 2008, Dr. Koontz was the clinical pharmacy specialist for over 10 years at the Children's Cancer Hospital at the University of Texas M. D. Anderson Cancer Center.